TY - JOUR
T1 - Complete Regression of Mouse Mammary Carcinoma with a Size Greater than 15 mm by Frequent Repeated Hyperthermia Using Magnetite Nanoparticles
AU - Ito, Akira
AU - Tanaka, Kouji
AU - Honda, Hiroyuki
AU - Abe, Shigeru
AU - Yamaguchi, Hideyo
AU - Kobayashi, Takeshi
N1 - Funding Information:
the magnetite. This work was partially supported by Grants-in-Aid for Scientific Research (no. 11227202, 13853005 and 15760587) the 21st Century COE Program “Nature-Guided Materials Processing” and the University Start-Up Creation Support System from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
PY - 2003
Y1 - 2003
N2 - Magnetite cationic liposomes (MCLs) have a positive surface charge and are used as a heating mediator for hyperthermia, because they generate heat in an alternating magnetic field (AMF) due to hysteresis loss. In our previous paper, hyperthermia using MCLs was applied to animals having several types of tumors in mice, rats, hamsters, and rabbits, and a strong anticancer effect was observed. For mice, complete tumor regression was observed when the tumor size was smaller than 5 mm. However, a protocol for large tumors is necessary for the clinical application. In the present paper, a protocol for tumors with a size greater than 15 mm in mice was investigated. MCLs were injected into an MM46 tumor (size, 15 mm) in C3H/HeN mice, which were subjected to AMF for 30 min. The temperature at the surface of the tumor reached 45°C and was maintained by controlling the magnetic field intensity. Hyperthermia treatment was repeated twice with 24-h intervals (repeated hyperthermia; RH), and RH was carried out until complete tumor regression was observed. Complete tumor regression was achieved in all mice treated once, twice or six times with RH, and mice acquired antitumor immunity. This protocol, which is termed frequent RH, is a potent approach for cancer therapy.
AB - Magnetite cationic liposomes (MCLs) have a positive surface charge and are used as a heating mediator for hyperthermia, because they generate heat in an alternating magnetic field (AMF) due to hysteresis loss. In our previous paper, hyperthermia using MCLs was applied to animals having several types of tumors in mice, rats, hamsters, and rabbits, and a strong anticancer effect was observed. For mice, complete tumor regression was observed when the tumor size was smaller than 5 mm. However, a protocol for large tumors is necessary for the clinical application. In the present paper, a protocol for tumors with a size greater than 15 mm in mice was investigated. MCLs were injected into an MM46 tumor (size, 15 mm) in C3H/HeN mice, which were subjected to AMF for 30 min. The temperature at the surface of the tumor reached 45°C and was maintained by controlling the magnetic field intensity. Hyperthermia treatment was repeated twice with 24-h intervals (repeated hyperthermia; RH), and RH was carried out until complete tumor regression was observed. Complete tumor regression was achieved in all mice treated once, twice or six times with RH, and mice acquired antitumor immunity. This protocol, which is termed frequent RH, is a potent approach for cancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=0344197472&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344197472&partnerID=8YFLogxK
U2 - 10.1263/jbb.96.364
DO - 10.1263/jbb.96.364
M3 - Article
C2 - 16233538
AN - SCOPUS:0344197472
SN - 1389-1723
VL - 96
SP - 364
EP - 369
JO - Journal of Bioscience and Bioengineering
JF - Journal of Bioscience and Bioengineering
IS - 4
ER -